Accelerated Pharma (Accelerated Pharma) LT-Debt-to-Total-Asset : 6.21 (As of Mar. 2017)

View and export this data going back to 2016. Start your Free Trial

What is Accelerated Pharma LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Accelerated Pharma's long-term debt to total assests ratio for the quarter that ended in Mar. 2017 was 6.21.

Accelerated Pharma's long-term debt to total assets ratio increased from Mar. 2016 (0.00) to Mar. 2017 (6.21). It may suggest that Accelerated Pharma is progressively becoming more dependent on debt to grow their business.

Accelerated Pharma LT-Debt-to-Total-Asset Historical Data

The historical data trend for Accelerated Pharma's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Accelerated Pharma LT-Debt-to-Total-Asset Chart

Accelerated Pharma Annual Data

Trend

Dec14

Dec15

Dec16

LT-Debt-to-Total-Asset

0.73

8.24

Accelerated Pharma Quarterly Data
	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial			-	3.53	5.21	8.24	6.21

Accelerated Pharma LT-Debt-to-Total-Asset Calculation

Accelerated Pharma's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2016 is calculated as

LT Debt to Total Assets (A: Dec. 2016 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2016 )	/	Total Assets (A: Dec. 2016 )
	=	1.211	/	0.147
	=

Accelerated Pharma's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2017 is calculated as

LT Debt to Total Assets (Q: Mar. 2017 )	=	Long-Term Debt & Capital Lease Obligation (Q: Mar. 2017 )	/	Total Assets (Q: Mar. 2017 )
	=	1.229	/	0.198
	=

Accelerated Pharma (NAS:ACCP) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Accelerated Pharma LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Accelerated Pharma's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Accelerated Pharma (Accelerated Pharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Accelerated Pharma Inc (NAS:ACCP) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

Accelerated Pharma Inc, is a Delaware corporation organized on May 12, 2014. It is a biopharmaceutical company focused on utilizing its genomic technology to enhance the development and commercialization of pharmaceutical products. Its lead product candidate is Picoplatin, a new generation platinum-based cancer therapy that has the potential for use in different formulations, as a single agent or in combination with other anti-cancer agents, to treat multiple cancer indications.

Accelerated Pharma (Accelerated Pharma) Headlines

No Headlines